Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium nitroprusside in adults with symptomatic schizophrenia
NCT02164981Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- May 2015
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sodium nitroprusside in schizophrenia, sponsored by Massachusetts General Hospital. Started May 2015; status: completed.
02
Drugs
sodium nitroprusside
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT02164981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02164981.